ExploreWatchlistsPricing
  1. US-listed companies
  2. Jaguar Health, Inc.
  3. Financials
  4. Stock-based compensation

Jaguar Health, Inc. (JAGX)

Market cap
$37.89M
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 20251-49.36%
Dec 31, 20242-22.30%
Dec 31, 20232-36.35%
Dec 31, 20223-16.51%
Dec 31, 20214+40.72%
Dec 31, 20203-5.51%
Dec 31, 20193+47.66%
Dec 31, 20182+148.45%
Dec 31, 20171+13.47%
Dec 31, 20161-27.64%
Dec 31, 20151

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat